Florida Atlantic University (FAU) researchers are working on a groundbreaking self-testing platform for HIV to address the global need for improved diagnostics.
Despite advancements in antiretroviral therapy (ART), effective HIV treatment faces challenges, including barriers to timely diagnostics during acute infections.
A significant percentage of individuals with HIV are unaware of their status, highlighting the importance of accessible testing methods.
FAU's self-testing technology, funded by a $1.3 million NIH grant, aims to revolutionize HIV diagnostics with a cost-effective and user-friendly solution.
The new technology's anticipated cost is less than $5 per test, offering a substantial reduction compared to current methods.
The handheld device provides automated results within 40 minutes, simplifying the testing process and improving accessibility for users.
Leveraging advanced technologies, including microchip fabrication and microfluidics, FAU's project targets accurate HIV detection from whole blood samples.
The technology's portability and low cost empower individuals to manage their health effectively, enhancing public health outcomes and reducing transmission rates.
The innovative self-testing program at FAU reflects a significant advancement in global public health strategies for combating HIV and other infectious diseases.
Collaboration with clinicians specializing in pathology and infectious diseases ensures that the self-testing development meets clinical standards and real-world healthcare challenges.